SCH 23390 - the first selective dopamine D-1 antagonist.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  European Journal of Pharmacology

• Publication date

  1983-07-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0014-2999(83)90381-3PMID 6225651
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preferential Labelling of Adenylate Cyclase Coupled Dopamine Receptors with Thioxanthene Neuroleptics

  1982cited by this paper
• Decreased antistereotypic effect of neuroliptics after additional treatment with a benzodiazepine, a GABA agonist or an anticholinergic compound.

  1979cited by this paper
• Effects of neuroleptics on 3H-haloperidol and 3H-cis(Z)-flupenthixol binding and on adenylate cyclase activity in vitro.

  1978cited by this paper
• Subcellular localization of dopamine-sensitive adenylate cyclase and dopamine receptor binding activities.

  1978cited by this paper

• Enhancement of D1 dopaminergic responses in aged LRRK2 G2019S knock-in mice.

  2025influential citation
• Nucleus accumbens core dopamine D2 receptors are required for performance of the odor span task in male rats

  2024cites this paper
• Endothelium-Derived Dopamine and 6-Nitrodopamine in the Cardiovascular System

  2023cites this paper
• Dopamine and noradrenaline activate spinal astrocyte endfeet via D1‐like receptors

  2023cites this paper
• Dopaminergic signaling regulates zebrafish larvae's response to electricity

  2022cites this paper
• The Signaling and Pharmacology of the Dopamine D1 Receptor

  2022cites this paper
• Synthesis of Chiral Tetrahydro-3-benzazepine Motifs by Iridium-Catalyzed Asymmetric Hydrogenation of Cyclic Ene-carbamates

  2022cites this paper
• Dopamine, Erectile Function and Male Sexual Behavior from the Past to the Present: A Review

  2022cites this paper
• Pyrazole-containing pharmaceuticals: target, pharmacological activity, and their SAR studies.

  2022cites this paper
• Ligand recognition and biased agonism of the D1 dopamine receptor

  2022cites this paper
• Zebrafish Larvae's Response to Electricity is Mediated by Dopaminergic Agonists and Antagonists

  2021cites this paper
• Dopaminergic Modulation of Basal Forebrain Cholinergic Neurons

  2021cites this paper
• 6-Nitrodopamine is an endogenous mediator of rat isolated epididymal vas deferens contractions induced by electric-field stimulation.

  2021cites this paper
• Opposite effects of dopamine on the mechanical activity of circular and longitudinal muscle of human colon

  2020cites this paper
• PET radioligands for the dopamine D1-receptor: Application in psychiatric disorders.

  2019cites this paper
• Advances in Dopamine D1 Receptor Ligands for Neurotherapeutics.

  2019cites this paper
• Age-Related Dopaminergic Innervation Augments T Helper 2-Type Allergic Inflammation in the Postnatal Lung.

  2019cites this paper
• Allosteric Modulators of Sigma-1 Receptor: A Review

  2019cites this paper
• Orexin‐mediated restoration of hippocampal synaptic potentiation in mice with established cocaine‐conditioned place preference

  2018cites this paper
• The Role of Dorsal Hippocampal Dopamine D1-Type Receptors in Social Learning, Social Interactions, and Food Intake in Male and Female Mice

  2017cites this paper
• Impact of the administration of α-casozepine, a benzodiazepine-like peptide from bovine αs1-casein, and of a proteolysis fragment on neural activity in mice

  2017cites this paper
• Neurotransmitter receptor availability in the rat brain is constant in a 24 hour-period

  2017cites this paper
• Polypharmacology of dopamine receptor ligands.

  2016cites this paper
• Dopamine D2 Receptors Enhance Population Dynamics in Primate Prefrontal Working Memory Circuits

  2016cites this paper
• Dopamine D1 receptor activity is involved in the increased anxiety levels observed in STZ-induced diabetes in rats.

  2016cites this paper
• Assessment of Motor Function in Rodents: Behavioral Models Sharing Simplicity and Multifaceted Applicability

  2016cites this paper
• Revealing the Neuroendocrine Response After Remoxipride Treatment Using Multi-Biomarker Discovery and Quantifying It by PK/PD Modeling

  2016cites this paper
• Timing of SCH 23390 administration influences extinction of conditioned hyperactivity in mice

  2016cites this paper
• Role of D1 receptor antagonism in contextual fear learning and memory

  2015cites this paper
• Wireless Optofluidic Systems for Programmable In Vivo Pharmacology and Optogenetics.

  2015influential citation
• Calcium and Phospholipase Cβ Signaling Through Dopamine Receptors

  2015cites this paper
• Neuro-anatomic mapping of dopamine D1 receptor involvement in nicotine self-administration in rats.

  2015cites this paper
• Effect of dopamine D1 and D2 receptor antagonism in the lateral hypothalamus on the expression and acquisition of fructose-conditioned flavor preference in rats.

  2014influential citation
• Dopamine Receptors and the Persistent Neurovascular Dysregulation Induced by Methamphetamine Self-Administration in Rats

  2014cites this paper
• Distinct dopaminergic control of the direct and indirect pathways in reward-based and avoidance learning behaviors.

  2014cites this paper
• Modulation of N-methyl-D-aspartate receptors by Gαs- and Gαi/o-coupled receptors

  2013cites this paper
• Modulation of ventral tegmental area dopamine receptors inhibit nicotine-induced anxiogenic-like behavior in the central amygdala.

  2013cites this paper
• Efficient catalyst-free four-component synthesis of novel γ-aminoethers mediated by a Mannich type reaction.

  2013cites this paper
• Modulating dopamine receptors subtype selectivity by thiophene and benzothiophene based derivatives

  2013cites this paper
• Acute administration of dopaminergic drugs has differential effects on locomotion in larval zebrafish.

  2013cites this paper
• Catalytic enantioselective synthesis of the dopamine D1 antagonist ecopipam

  2012cites this paper
• In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels.

  2012cites this paper
• Mephedrone ("bath salt") pharmacology: insights from invertebrates.

  2012cites this paper
• Subtype-selective dopamine receptor radioligands for PET imaging: current status and recent developments.

  2012cites this paper
• The intercalated paracapsular islands as a module for integration of signals regulating anxiety in the amygdala.

  2012cites this paper
• Pathway-specific control of reward learning and its flexibility via selective dopamine receptors in the nucleus accumbens

  2012cites this paper
• Novel Benzindoloazecines and Dibenzazecines: synthesis and affinities for the Dopamine receptors

  2011cites this paper
• Differential Effects of Dopamine Receptor D1-Type and D2-Type Antagonists and Phase of the Estrous Cycle on Social Learning of Food Preferences, Feeding, and Social Interactions in Mice

  2011influential citation
• Conditioned fear is modulated by D2 receptor pathway connecting the ventral tegmental area and basolateral amygdala.

  2011cites this paper
• Impairments of exploration and memory after systemic or prelimbic D1-receptor antagonism in rats.

  2011cites this paper
• Synthesis and pharmacological evaluation of 5,6,7,8‐tetrahydro‐6‐[propyl[2‐(2‐thienyl)ethyl]amino]‐1,2‐naphthalenediol: A novel non‐selective dopamine‐receptor agonist

  2010cites this paper
• Screening and isolation of a natural dopamine D1 receptor antagonist using cell-based assays.

  2010cites this paper
• Age-related reduction in dopamine D1 receptors in the human brain: from late childhood to adulthood, a positron emission tomography study.

  2010cites this paper
• Drastic decrease in dopamine receptor levels in the striatum of acetylcholinesterase knock-out mouse.

  2010cites this paper
• The rotational model and microdialysis: Significance for dopamine signalling, clinical studies, and beyond.

  2010cites this paper
• D1 receptors play a major role in the dopamine modulation of mouse ileum contractility.

  2010cites this paper
• Role of dopamine receptor mechanisms in the amygdaloid modulation of fear and anxiety: Structural and functional analysis.

  2010cites this paper
• A Novel Construction of 2-Benzazepine Scaffold Based on TiCl4-Mediated Tandem Mannich Reaction–Aromatic Electrophilic Substitution

  2009cites this paper
• Dopamine D4 receptor antagonist L745,870 abolishes cognitive effects of intracerebroventricular angiotensin IV and des-Phe(6)-Ang IV in rats.

  2009cites this paper
• Further studies of the mechanism behind scopolamine-induced reversal of antistereotypic and cataleptogenic effects of neuroleptics in rats.

  2009cites this paper
• Mechanisms of Action of Antipsychotic Drugs of Different Classes, Refractoriness to Therapeutic Effects of Classical Neuroleptics, and Individual Variation in Sensitivity to their Actions: PART I

  2009cites this paper
• The citalopram/5-HTP-induced head shake syndrome is correlated to 5-HT2 receptor affinity and also influenced by other transmitters.

  2009cites this paper
• Role of dopamine receptors in the ventral tegmental area in conditioned fear.

  2009cites this paper
• The benzazepine, SCH 23390, inhibits 3H-NPA binding in mouse brain in vivo.

  2009cites this paper
• Pharmacological Analysis of Human D1 and D2 Dopamine Receptor Missense Variants

  2008cites this paper
• Dopamine receptors in human lymphocytes: radioligand binding and quantitative RT-PCR assays.

  2008cites this paper
• Characterization of dopamine D1 receptor agonists in vivo- Implications for the treatment of schizophrenia and Parkinson s disease

  2008cites this paper
• D1-like Dopamine Receptors

  2008cites this paper
• Characterization of dopamine D 1 receptor agonists in vivo-Implications for the treatment of schizophrenia and Parkinson ’ s disease

  2008cites this paper
• Exploring neurocircuitries of the basal ganglia by intracerebral administration of selective neurotoxins

  2007cites this paper
• Effects of dopamine D1-like receptor agonists on food-maintained operant behavior in rats

  2006cites this paper
• SCH 23390: the first selective dopamine D1-like receptor antagonist.

  2006cites this paper
• Apomorphine anorexia: the role of dopamine receptors in the ventral forebrain

  2006cites this paper
• PET tracers for imaging of the dopaminergic system.

  2006cites this paper
• Serotonin 2A receptor antagonist treatment reduces dopamine D1 receptor-mediated rotational behavior but not L-DOPA-induced abnormal involuntary movements in the unilateral dopamine-depleted rat.

  2006influential citation
• FOR THE DEGREE CANDIDATA PHARMACIAE SYNAPSIN I / II DOUBLE KNOCKOUT MICE AND SPONTANEOUSLY HYPERTENSIVE RATS ; TWO ANIMAL MODELS WITH IMPLICATIONS FOR NEUROLOGICAL DISORDERS by ŠAHA GRABOVAC

  2006cites this paper
• Dopamine D2 receptor mechanisms in the expression of conditioned fear.

  2006cites this paper
• Dopamine-D1 and -D2 receptors differentially regulate synapsin II expression in the rat brain.

  2006cites this paper
• Acute lead exposure and contraction of rat isolated aorta induced by D1-dopaminergic and alpha-adrenergic drugs.

  2006cites this paper
• Drugs acting at D-1 and D-2 dopamine receptors induce identical purposeless chewing in rats which can be differentiated by cholinergic manipulation

  2005cites this paper
• Antagonism of behavioral effects of cocaine by selective dopamine receptor blockers

  2005cites this paper
• A rat model of distractibility: effects of drugs modifying dopaminergic, noradrenergic and GABA ergic neurotransmission

  2005cites this paper
• Effects of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin on the dopaminergic and cholinergic receptors as evaluated by positron emission tomography in the Rhesus monkey

  2005cites this paper
• Human dopamine receptor subtypes—in vitro binding analysis using3H-SCH 23390 and3H-raclopride

  2005influential citation
• PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor

  2005cites this paper
• Age-related changes in human D1 dopamine receptors measured by positron emission tomography

  2005cites this paper
• Analgesic and discriminative stimulus properties of U-62,066E, the selective kappa-opioid receptor agonist, in the rat

  2005cites this paper
• In vivo receptor binding, neurochemical and functional studies with the dopamine D-1 receptor antagonist SCH 23390

  2005cites this paper
• Quantification of SCH 39166, a novel selective D1 dopamine receptor antagonist, in rat brain and blood

  2005cites this paper
• Inhibition of SKF 38393- and pergolide-induced circling in rats with unilateral 6-OHDA lesion is correlated to dopamine D-1 and D-2 receptor affinitiesin vitro

  2005cites this paper
• Dopamine-receptor agonists: Mechanisms underlying autoreceptor selectivity

  2005cites this paper
• Selective D1- and D2-dopamine receptor blockade both induces akathisia in humans — a PET study with [11C]SCH 23390 and [11C]raclopride

  2005cites this paper
• Differential antagonism of the effects of dopamine D1-receptor agonists on feeding behavior in the rat

  2005cites this paper
• Dopamine D1 (SCH 23390) and D2 (haloperidol) antagonists in drug-naive monkeys

  2005cites this paper
• Raclopride, but not SCH 23390, induces maldirected jumping in rats trained to perform a run-climb-run behavioral task

  2005cites this paper
• In vivo effects of estrogen and 2-hydroxyestradiol on D-2 dopamine receptor agonist affinity states in rat striatum

  2005cites this paper
• Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice

  2005cites this paper
• Characterization of binding of3H-SCH 23390 to dopamine D-1 receptors. Correlation to other D-1 and D-2 measures and effect of selective lesions

  2005cites this paper
• Effects of selective D1 and D2 dopamine antagonists on cocaine self-administration in the rat

  2005cites this paper
• D1 receptor binding in rat striatum: modification by various D1 and D2 antagonists, but not by sibutramine hydrochloride, antidepressants or treatments which enhance central dopaminergic function

  2005cites this paper